EUVIMEDEUVIMED entdecken
Crossref

Maximizing mesh mileage: evaluating the long-term performance of a novel hybrid mesh for ventral hernia repair

G J Spurzem iD, R C Broderick, J Z Li, B J Sandler, S Horgan, G R Jacobsen

Hernia · 2024

DOI: 10.1007/s10029-024-02995-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Hernia, 2024. Verfasst von G J Spurzem und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Division of Minimally Invasive Surgery, University of California San Diego, 9300 Campus Point Dr, La Jolla, CA, 92037, USA. gs…. Hauptthemen laut MEDLINE: Surgical Mesh, Hernia, Ventral, Herniorrhaphy, Recurrence. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: The objective of this study is to evaluate the safety and long-term outcomes of GORE Synecor™ in ventral hernia repair (VHR). METHODS: This retrospective, single-center case review analyzed outcomes in patients who underwent VHR with Synecor from May 2016 to December 2022. Primary outcomes were hernia recurrence and mesh infection rates. Secondary outcomes were 30-day morbidity, 30-day mortality, 30-day readmission, re-operation, surgical-site infection (SSI) and occurrence (SSO) rates, and occurrences requiring intervention (SSOI). RESULTS: 278 patients were identified. Mean follow-up was 24.1 (0.2-87.1) months. Mean hernia defect size was 63.4 (± 77.2) cm2. Overall hernia recurrence and mesh infection rates were 5.0% and 1.4% respectively. No mesh infections required full explantation. We report the following overall rates: 13.3% 30-day morbidity, 4.7% 30-day readmission, 2.9% re-operation, 7.2% SSI, 6.1% SSO, and 2.9% SSOI. 30-day morbidity was significantly higher in non-clean (42.1% vs 11.2%, p < 0.01), onlay (OL) mesh (37.0% vs preperitoneal (PP) 16.4%, p = 0.05 vs retrorectus (RR) 15.0%, p < 0.05 vs intraperitoneal (IP) 5.2%, p < 0.001), and open cases (23.5% vs 3.1% laparoscopic vs 4.4% robotic, p < 0.01). SSI rates were significantly higher in non-clean (31.6% vs 5.4%, p < 0.001), OL mesh (29.6% vs RR 11.3%, p < 0.05 vs PP 5.5%, p < 0.01 vs IP 0.0%, p < 0.001), and open cases (15.2% vs 0% laparoscopic vs 0% robotic, p < 0.05). CONCLUSION: Long-term performance of a novel hybrid mesh in VHR demonstrates a low recurrence rate and favorable safety profile in various defect sizes and mesh placement locations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Surgical MeshHernia, VentralHerniorrhaphyRecurrenceHumansRetrospective StudiesMaleFemaleMiddle AgedAgedPatient ReadmissionReoperationSurgical Wound InfectionAdultPostoperative Complications

Stichwörter der Autor:innen

Component separationHybrid meshPGA/TMCVentral hernia

Autor:innen und Institutionen

  • Department of Surgery, Division of Minimally Invasive Surgery, University of California San Diego, 9300 Campus Point Dr, La Jolla, CA, 92037, USA. gspurzem@health.ucsd.edu.
  • Department of Surgery, Division of Minimally Invasive Surgery, University of California San Diego, 9300 Campus Point Dr, La Jolla, CA, 92037, USA.

ORCID-Profile: G J Spurzem

Zitieren

APA

Spurzem, G. J., Broderick, R. C., Li, J. Z., Sandler, B. J., Horgan, S., & Jacobsen, G. R. (2024). Maximizing mesh mileage: evaluating the long-term performance of a novel hybrid mesh for ventral hernia repair. Hernia. https://doi.org/10.1007/s10029-024-02995-0

Vancouver

Spurzem GJ, Broderick RC, Li JZ, Sandler BJ, Horgan S, Jacobsen GR. Maximizing mesh mileage: evaluating the long-term performance of a novel hybrid mesh for ventral hernia repair. Hernia. 2024. doi:10.1007/s10029-024-02995-0

BibTeX
@article{Spurzem2024,
  author = {Spurzem, G J and Broderick, R C and Li, J Z and Sandler, B J and Horgan, S and Jacobsen, G R},
  title = {Maximizing mesh mileage: evaluating the long-term performance of a novel hybrid mesh for ventral hernia repair},
  journal = {Hernia},
  year = {2024},
  doi = {10.1007/s10029-024-02995-0}
}
Kostenlos starten →